Global Health Clinics (MJRX) AI Stock Analysis

• Market Cap: C$281.76K
• Dividend Yield: N/A
• Average Volume (3M): 7.79K
• Price to Earnings (P/E): ―
• Beta (1Y): -2.51
• Revenue Growth: -42.42%
• EPS Growth: -17.33%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 9,392,138
• 10 Day Avg. Volume: 900
• 30 Day Avg. Volume: 7,790
• PEG Ratio: <0.01
• Price to Book (P/B): -0.04
• Price to Sales (P/S): 1.70
• P/FCF Ratio: -0.28
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 28 Underperform
• Price Target: ―

The overall stock score for Global Health Clinics is significantly low due to its dire financial condition, marked by continuous operating losses, high leverage, and negative cash flows. Technical analysis also reflects a lack of positive momentum, and valuation metrics reveal the stock as unattractive to investors. Without any positive earnings call or corporate events to offset these issues, the stock remains a high-risk investment.

Global Health Clinics Business Overview & Revenue Model

Company Description

Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of marijuana. It also engages in developing psilocybin products for research and usage for pharmaceutical purposes. The company was formerly known as Leo Resources Inc. and changed its name to Global Health Clinics Ltd. in August 2018. Global Health Clinics Ltd. was incorporated in 2013 and is headquartered in Vancouver, Canada.

How the Company Makes Money

Global Health Clinics (MJRX) generates revenue primarily through the provision of healthcare services at its clinics. Patients pay for medical consultations, treatments, and health programs either directly or through insurance reimbursements. Additionally, the company may earn income from partnerships with healthcare providers and wellness product suppliers, as well as from offering specialized health programs that could have subscription-based models. The ability to attract and retain patients, as well as maintaining partnerships with insurance companies and healthcare providers, are crucial factors contributing to MJRX's earnings.

Global Health Clinics Financial Statement Overview

Summary

Global Health Clinics is in a precarious financial state, characterized by continuous losses, high leverage, and negative equity. Revenue and cash flow trends are deteriorating, suggesting significant operational and financial restructuring is needed to achieve stability. The company's current trajectory poses substantial risks to future viability.

Income Statement

The company's income statement reveals significant financial distress, with consistent negative net income and declining revenue trends. The gross profit margin is relatively healthy, but the net profit margin is severely negative due to high operating losses. Revenue has shown a negative growth trajectory, exacerbating financial challenges.

Balance Sheet

The balance sheet indicates severe financial instability with negative stockholders' equity, high debt levels, and a negative equity ratio. The debt-to-equity ratio is undefined due to negative equity, highlighting extreme leverage and potential insolvency risks. Asset levels are quite low compared to liabilities, underscoring financial vulnerability.

Cash Flow

Cash flow analysis shows persistent negative operating and free cash flows, reflecting ongoing liquidity issues. The operating cash flow to net income ratio is negative, indicating insufficient cash generation relative to losses. The company relies heavily on financing activities to cover cash outflows, which is unsustainable in the long term.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	61.96K	47.77K	82.96K	102.85K	146.81K	225.09K
Gross Profit	54.85K	-515.73K	63.88K	80.64K	116.00K	177.75K
EBITDA	-1.05M	-1.05M	-947.00K	-1.57M	-1.35M	-8.34M
Net Income	-1.24M	-1.27M	-1.08M	-1.63M	-1.37M	-8.48M
Balance Sheet
Total Assets	17.07K	66.14K	29.33K	241.50K	578.81K	610.60K
Cash, Cash Equivalents and Short-Term Investments	4.86K	50.48K	9.19K	214.34K	496.69K	456.26K
Total Debt	2.10M	1.91M	1.52M	1.10M	322.31K	30.81K
Total Liabilities	4.19M	4.59M	3.29M	2.43M	1.14M	1.05M
Stockholders Equity	-4.17M	-4.53M	-3.26M	-2.18M	-559.58K	-440.39K
Cash Flow
Free Cash Flow	-599.24K	-572.21K	-496.55K	-1.01M	-1.49M	-825.80K
Operating Cash Flow	-599.24K	-572.21K	-496.55K	-1.01M	-1.49M	-825.80K
Investing Cash Flow	0.00	0.00	0.00	0.00	0.00	428.97K
Financing Cash Flow	584.50K	613.50K	291.40K	727.48K	1.53M	763.22K

Global Health Clinics Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.03
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MJRX, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.03, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 45.72 is Neutral, neither overbought nor oversold. The STOCH value of 63.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:MJRX.

Global Health Clinics Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
LOWL	34 Underperform	C$272.55K	-0.01	―	―	―	―
MJRX	28 Underperform	C$281.76K	-0.21	―	―	-42.42%	-17.33%
XCX	23 Underperform	C$258.28K	-0.40	5.70%	―	―	-406.12%